Skip to content

Docteur Pascal NAGYPAL

Active
Private limited companyfounded 2006active for 19 yearsRue du Chêne Brûlé 14, 7370 Dour, BelgiumKBO/BCE: BE 0885.977.907

From the official registers: KBO 18 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Docteur Pascal NAGYPAL has been active since 2006 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €202,710 and a net result of €75,214. Equity has been growing by about 26% per year since 2019. Its solvency ranks better than 48% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

KBO
Status
Active since 28-12-2006 Normal situation
Activity
Specialist medical practice NACE 86220
Financial year end
30 June
Peppol
Reachable since 16-11-2024

Board and ownership

Board
  • Nagypal PascalDirector

Financial position

93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts to 30-06-2025
Gross margin
€109,229
▼ 8.7%
Turnover
≈ €200,000
estimated
Profit
€75,214
▲ 4.1%
Equity
€202,710
▼ 7.5%
Total assets
€332,158
▲ 20.0%
Filed on 30-01-2026, 1 day before the deadlinePDF
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 2.50, cash €72,911Size: total assets €332,158Equity €202,710 (61.0% of total assets)Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 43% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 86-14
equity 61.0% of total assets
Liquidity 61-1
short-term debt 37.1% · cash 22.0%
Profitability 97-3
return on assets 22.6%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: 0.1%▲ +0.1 percentage points vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025highest value 03-2025: < 0.1%▼ -0.1 percentage points vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: 0.1%▲ +0.1 percentage points vs 01-2026 03-2026: < 0.1%▼ -0.1 percentage points vs 02-2026lowest value 04-2026: < 0.1%● unchanged vs 03-2026lowest value 05-2026: < 0.1%● unchanged vs 04-2026lowest value 06-2026: < 0.1%● unchanged vs 05-2026lowest value 07-2026: < 0.1%● unchanged vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €18,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.5 (4.44 in 2024), above the usual 1.5. Short-term debt is 37.1% and cash 22% of total assets. 39% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 49% of them on solvency, 38% on liquidity, 57% on profitability and 28% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 2.50, cash €72,911
NBB · annual accounts
lowers risk · Size: total assets €332,158
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Equity €202,710 (61.0% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 30-01-2026, 1 day ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
1 day early
2024
4 days late
2023
on the day
2022
on the day
2021
on the day
2020
2 days early
2019
31 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 4 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 31 January (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
30-06-2026 year end01-11-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: 7th oldest company in Dour, Health and social work sectorin the Checked rankings No. 7 View
  • Positive: 7 profitable years in a rowprofit 2025: €75,214 7 years View

Comparable companies

These companies have the same main activity as Docteur Pascal NAGYPAL: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €294,000 and €350,000, founded between 2006 and 2008.

CompanyTotal assetsGross margin
Docteur Pascal NAGYPAL Dour€332,158€109,229
DOCTEUR NATHALIE SCHRAYEN Braine-le-Comte€294,162€114,226
CURAXIS Sint-Martens-Latem€328,370€106,333
Dr JC DONNAY Anesthésie Réanimation Neufchâteau€349,614€110,795
Dokter Lasser, hepatogastroenteroloog Ganshoren€348,536€104,740
Dr. Sophie SERVAES Koksijde€306,982€114,430
DECLEIRE LAURENT Sint-Pieters-Woluwe€302,594€104,133
Full comparison

Documents

Annual accounts at the NBB

All 18 annual accounts

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about Docteur Pascal NAGYPAL

What is the company number of Docteur Pascal NAGYPAL?
The company number of Docteur Pascal NAGYPAL is 0885.977.907. The VAT number is the same number with BE in front: BE 0885.977.907.
Where is Docteur Pascal NAGYPAL based?
The registered office is at Rue du Chêne Brûlé 14, 7370 Dour.Company details
What does Docteur Pascal NAGYPAL do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Docteur Pascal NAGYPAL?
The legal form of Docteur Pascal NAGYPAL is Private limited company (BV).
When was Docteur Pascal NAGYPAL founded?
Docteur Pascal NAGYPAL was founded on 28-12-2006.
Is Docteur Pascal NAGYPAL still active?
Yes, Docteur Pascal NAGYPAL is an active enterprise in the KBO register.
What is the turnover of Docteur Pascal NAGYPAL?
The turnover in financial year 2025 is ≈ €200,000. This figure is estimated from the gross margin of €109,229 and 43 comparable companies (NACE 86220). It probably lies between €170,000 and €270,000. In financial year 2023 turnover was €0.Financials
Is Docteur Pascal NAGYPAL profitable?
In financial year 2025, Docteur Pascal NAGYPAL made a profit of €75,214.
Where can I find the annual accounts of Docteur Pascal NAGYPAL?
Docteur Pascal NAGYPAL filed 18 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
When are the next annual accounts of Docteur Pascal NAGYPAL due?
Docteur Pascal NAGYPAL must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.